Difference between revisions of "Team:KU Leuven"
| Line 522: | Line 522: | ||
<div class="el__bg"></div> | <div class="el__bg"></div> | ||
<div class="el__preview-cont"> | <div class="el__preview-cont"> | ||
| − | <h2 class="el__heading"> | + | <h2 class="el__heading">KU Leuven</h2> |
</div> | </div> | ||
<div class="el__content"> | <div class="el__content"> | ||
| Line 544: | Line 544: | ||
<div class="el__bg"></div> | <div class="el__bg"></div> | ||
<div class="el__preview-cont"> | <div class="el__preview-cont"> | ||
| − | <h2 class="el__heading"> | + | <h2 class="el__heading">Project</h2> |
</div> | </div> | ||
<div class="el__content"> | <div class="el__content"> | ||
| − | <div class="el__text"> | + | <div class="el__text">Inspired by the heart<br> |
| + | <br> | ||
| + | We drew our inspiration from the versatility and robustness of the <b>heart</b>. It beats continuously over the years, rapidly <b>adapting its pace</b> when necessary.</div> | ||
<div class="el__close-btn"></div> | <div class="el__close-btn"></div> | ||
| Line 572: | Line 574: | ||
<div class="el__text">Inspired by the heart</div> | <div class="el__text">Inspired by the heart</div> | ||
<br> | <br> | ||
| − | <p> | + | <p></p> |
<div class="el__close-btn"></div> | <div class="el__close-btn"></div> | ||
</div> | </div> | ||
Revision as of 00:34, 14 September 2017
KU Leuven
HEKcite
1
Project
Inspired by the heart
We drew our inspiration from the versatility and robustness of the heart. It beats continuously over the years, rapidly adapting its pace when necessary.
We drew our inspiration from the versatility and robustness of the heart. It beats continuously over the years, rapidly adapting its pace when necessary.
2
Project
Inspired by the heart
3
Research
Creation of the Rhythm
Given our knowledge about heart currents, we hypothesized it would be possible to recreate a steady rhythm in a non-excitable cell using only three ion channels.
4
Application
Biosensing
Finally, we aim to influence the pace by varying concentrations of biological effectors. Our main focus is establishing a new form of therapeutic drug monitoring.
5
